California health centers that participate in the 340B program recently appealed a federal district judge’s dismissal of a suit to reverse [...] …
Month: September 2023
SPONSORED CONTENT
For over 35 years, Avita Care Solutions’ Chief Medical Officer, Dr. Christopher Hall, has devoted his career to democratizing and scaling compassionate and competent care initiatives to underserved communities—the very patients the 340B program was designed to help. In the following interview, he offers
…
An independent cancer care practice is suing a Philadelphia health system in federal court over a range of alleged anti-competitive [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two drugmakers owe repayment to 340B covered entities, according to final audits posted this week by federal officials. American Health [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Eligible covered entities in Georgia may enroll in the 340B program immediately, rather than having to wait for the next [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
TIP: Keep the complicated operations of your 340B program compliant with the expertise of the Apexus Advanced 340B Operations Certificate Program.
Drug manufacturer Jazz Pharmaceuticals this week became the 25th drug manufacturer to impose conditions on 340B pricing involving delivery to contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug manufacturer Sanofi recently started denying access for some health centers to 340B pricing at contract pharmacies after previously saying [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
The landscape of HIV control looks very different than it did 30 years ago. In the early days of the epidemic, most people living with HIV didn’t know they had the virus. Our main challenge was finding them, testing them, and getting them
…
A Sept. 14 House subcommittee hearing will review draft legislation, which would exclude certain generic drugs from the 340B program [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
×
*Sign up for news summaries and alerts from 340B Report